Poly(galactaramidoamine) is an efficient cationic polymeric non-viral vector with low cytotoxicity for transfecting human embryonic kidney (HEK293) and murine macrophage (RAW264.7) cells

Poly(galactaramidoamine) (PGAA) is a cationic co-polymer of dimethyl-meso-galactarate and pentaethylenehexamine. PGAA electrostatically complexes with plasmid DNA (pDNA) to form nano-sized particles. In this study, we show that PGAA-pDNA polyplexes generate high transfection efficiencies in human embryonic kidney (HEK293) and murine macrophage-like (RAW264.7) cell lines. PGAA-pDNA mediated transfection is a function of the amine:phosphate (N/P) ratio at which the polyplexes are prepared. The maximum expression of luciferase was obtained using polyplexes prepared at an N/P ratio of 40. Polyplexes prepared at increasing N/P ratios did not significantly increase in size but did result in decreasing luciferase expression. Cellular toxicity increased as the N/P ratios at which the polyplexes were prepared increased.

[1]  T. Smart,et al.  HEK293 cell line: a vehicle for the expression of recombinant proteins. , 2005, Journal of pharmacological and toxicological methods.

[2]  A. Salem,et al.  Characterization of the transgene expression generated by branched and linear polyethylenimine-plasmid DNA nanoparticles in vitro and after intraperitoneal injection in vivo. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[3]  T. Reineke,et al.  Hydroxyl stereochemistry and amine number within poly(glycoamidoamine)s affect intracellular DNA delivery. , 2005, Journal of the American Chemical Society.

[4]  A. Salem,et al.  Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells , 2011, Journal of drug targeting.

[5]  T. Reineke,et al.  Poly(glycoamidoamine)s for gene delivery: stability of polyplexes and efficacy with cardiomyoblast cells. , 2006, Bioconjugate chemistry.

[6]  T. Reineke,et al.  Interaction of poly(glycoamidoamine) DNA delivery vehicles with cell-surface glycosaminoglycans leads to polyplex internalization in a manner not solely dependent on charge. , 2010, Molecular pharmaceutics.

[7]  N. Ingle,et al.  Poly(glycoamidoamine)s: a broad class of carbohydrate-containing polycations for nucleic acid delivery. , 2011, Trends in biotechnology.

[8]  T. Reineke,et al.  New poly(d-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. , 2004, Journal of the American Chemical Society.

[9]  T. Reineke,et al.  Poly(glycoamidoamine) vehicles promote pDNA uptake through multiple routes and efficient gene expression via caveolae-mediated endocytosis. , 2010, Molecular pharmaceutics.

[10]  A. Salem,et al.  Optimized dextran-polyethylenimine conjugates are efficient non-viral vectors with reduced cytotoxicity when used in serum containing environments. , 2012, International journal of pharmaceutics.

[11]  T. Reineke,et al.  Degradation of poly(glycoamidoamine) DNA delivery vehicles: polyamide hydrolysis at physiological conditions promotes DNA release. , 2010, Biomacromolecules.

[12]  Ashley M. Jacobi,et al.  Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA. , 2012, International journal of pharmaceutics.